Date: 2016-09-23
Type of information: Nomination
Compound:
Company: Merck KGaA (Germany)
Therapeutic area:
Type agreement: nomination
Action mechanism:
Disease:
Details: * On September 23, 2016, Merck KGaA announced that Isabel De Paoli (42) has been appointed Chief Strategy Officer effective Oct. 1, 2016. De Paoli will head the newly created Group Strategy and Transformation function, integrating existing strategy, innovation and digitalization initiatives across Merck. She will assume the new role in addition to her current position as Head of Group Communications for the time being and continue to report to Stefan Oschmann, CEO and Chairman of the Executive Board of Merck.
Financial terms:
Latest news:
